These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 18408528

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
    Lindenmayer JP, Eerdekens E, Berry SA, Eerdekens M.
    J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Generic quetiapine in the treatment of acute schizophrenia and schizoaffective disorder].
    György B, Robert K, László C, Andrea J, Ketilept Vizsgáló Munkacsoport.
    Neuropsychopharmacol Hung; 2008 Dec; 10(5):293-303. PubMed ID: 19419015
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Switching to quetiapine in patients with acute mania who were intolerant to risperidone.
    Pae CU, Lee KU, Kim JJ, Lee CU, Bahk WM, Lee SJ, Lee C, Paik IH.
    Hum Psychopharmacol; 2004 Jan; 19(1):47-51. PubMed ID: 14716712
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [An open study on the efficacy and tolerability of quetiapine treatment of patients with schizophrenia].
    Beszłej JA, Grzesiak M.
    Psychiatr Pol; 2005 Jan; 39(2):293-307. PubMed ID: 15881624
    [Abstract] [Full Text] [Related]

  • 10. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [Abstract] [Full Text] [Related]

  • 11. Quetiapine, a novel antipsychotic: experience in elderly patients with psychotic disorders. Seroquel Trial 48 Study Group.
    McManus DQ, Arvanitis LA, Kowalcyk BB.
    J Clin Psychiatry; 1999 May; 60(5):292-8. PubMed ID: 10362435
    [Abstract] [Full Text] [Related]

  • 12. Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder.
    Rossi A, Bagalà A, Del Curatolo V, Scapati F, Bernareggi MM, Giustra MG, Risperidone Long-Acting Trial Investigators (R-LAI).
    Hum Psychopharmacol; 2009 Oct; 24(7):574-83. PubMed ID: 19790173
    [Abstract] [Full Text] [Related]

  • 13. Quetiapine: efficacy, tolerability and safety in schizophrenia.
    Miodownik C, Lerner V.
    Expert Rev Neurother; 2006 Jul; 6(7):983-92. PubMed ID: 16831113
    [Abstract] [Full Text] [Related]

  • 14. A failed 6-week,randomized, double-blind, placebo-controlled study of once-daily extended release quetiapine fumarate in patients with acute schizophrenia: lessons learned.
    Cutler AJ, Tran-Johnson T, Kalali A, Aström M, Brecher M, Meulien D.
    Psychopharmacol Bull; 2010 Jul; 43(4):37-69. PubMed ID: 21240151
    [Abstract] [Full Text] [Related]

  • 15. Treatment of depressive symptoms in patients with schizophrenia: a randomized, open-label, parallel-group, flexible-dose subgroup analysis of patients treated with extended-release quetiapine fumarate or risperidone.
    Kasper S, Montagnani G, Trespi G, Di Fiorino M.
    Int Clin Psychopharmacol; 2015 Jan; 30(1):14-22. PubMed ID: 25356632
    [Abstract] [Full Text] [Related]

  • 16. Prolactin, subjective well-being and sexual dysfunction: an open label observational study comparing quetiapine with risperidone.
    Westheide J, Cvetanovska G, Albrecht C, Bliesener N, Cooper-Mahkorn D, Creutz C, Hornung WP, Klingmüller D, Lemke MR, Maier W, Schubert M, Sträter B, Kühn KU.
    J Sex Med; 2008 Dec; 5(12):2816-26. PubMed ID: 18466271
    [Abstract] [Full Text] [Related]

  • 17. A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning.
    Knegtering R, Castelein S, Bous H, Van Der Linde J, Bruggeman R, Kluiter H, van den Bosch RJ.
    J Clin Psychopharmacol; 2004 Feb; 24(1):56-61. PubMed ID: 14709948
    [Abstract] [Full Text] [Related]

  • 18. An open-label trial of quetiapine for antipsychotic-induced sexual dysfunction.
    Byerly MJ, Lescouflair E, Weber MT, Bugno RM, Fisher R, Carmody T, Varghese F, Rush AJ.
    J Sex Marital Ther; 2004 Feb; 30(5):325-32. PubMed ID: 15672600
    [Abstract] [Full Text] [Related]

  • 19. [Efficacy and tolerability of quetiapine in hospitalised schizophrenic patients during the acute treatment phase: a PMS study].
    Leweke FM, Gerth CW, Koethe D, Nolden BM, Klosterkötter J.
    Fortschr Neurol Psychiatr; 2007 Apr; 75(4):211-9. PubMed ID: 17230308
    [Abstract] [Full Text] [Related]

  • 20. [Long-term relapse prevention with risperidone in 215 schizophrenic patients].
    Udina Abelló C, Roca Bennasar M, Octavio Del Valle I.
    Actas Esp Psiquiatr; 2001 Apr; 29(4):243-9. PubMed ID: 11470059
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.